Klaus Pors
- Molecular Biology
- Oncology top 10%
- Organic Chemistry top 10%
- Cancer Research top 10%
- Pharmacology top 2%
- Co-authors
- Laurence H. PattersonJan S. MorebMark SearceyPaul M. LoadmanHelen M. SheldrakeSteven D. ShnyderGoreti Ribeiro MoraisJohn A. Hartley
- Topics
- Cancer therapeutics and mechanisms (19 papers)Pharmacogenetics and Drug Metabolism (13 papers)Cancer, Hypoxia, and Metabolism (9 papers)
- Partner nations
- United KingdomItalySpain
In The Last Decade
Klaus Pors
56 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 563
- Oncology 264
- Organic Chemistry 250
- Cancer Research 194
- Pharmacology 171
Countries citing papers authored by Klaus Pors
This map shows the geographic impact of Klaus Pors's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Pors with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Pors more than expected).
Fields of papers citing papers by Klaus Pors
This network shows the impact of papers produced by Klaus Pors. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Pors. The network helps show where Klaus Pors may publish in the future.
Co-authorship network of co-authors of Klaus Pors
This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Pors. A scholar is included among the top collaborators of Klaus Pors based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Pors. Klaus Pors is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 1 | |
| 4 | 11 | |
| 5 | 21 | |
| 6 | 3 | |
| 7 | 9 | |
| 8 | 22 | |
| 9 | 40 | |
| 10 | 1 | |
| 11 | 14 | |
| 12 | 7 | |
| 13 | 46 | |
| 14 | 88 | |
| 15 | 6 | |
| 16 | 46 | |
| 17 | 36 | |
| 18 | 13 | |
| 19 | 4 | |
| 20 | 47 |
About Klaus Pors
Klaus Pors is a scholar working on Pharmacology, Toxicology and Cancer Research, having authored 61 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (19 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Cancer, Hypoxia, and Metabolism (9 papers). The work is most often cited by research in Pharmacology (171 citations), Toxicology (45 citations) and Cancer Research (194 citations). Klaus Pors has collaborated with scholars based in United Kingdom, Italy and Spain. Frequent co-authors include Laurence H. Patterson, Jan S. Moreb, Mark Searcey, Paul M. Loadman, Helen M. Sheldrake, Steven D. Shnyder, Goreti Ribeiro Morais, John A. Hartley, Marco L. Lolli and Paul Teesdale‐Spittle. Their work appears in journals such as Cancer Research, Oncogene and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.